Don't Use Baxdela to Treat Most Skin Infections
November 2017
Baxdela (baks-DEH-lah, delafloxacin) is a new quinolone antibiotic.
So far it's only approved to treat skin infections.
It seems to have better coverage than other quinolones for gram-positive bacteria...including methicillin-resistant Staph aureus (MRSA).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote